Konstantinos Karmiris
Irakleion, ESYE43, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 89 publications
Effect of JAK inhibitors on extraintestinal manifestations and concurrent immune-mediated inflammatory diseases in patients with inflammatory bowel disease.
Journal: Journal of Crohn's & colitis
Published: September 05, 2026
ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease.
Journal: Journal of Crohn's & colitis
Published: July 08, 2026
Renal and urological complications in patients with inflammatory bowel disease.
Journal: European journal of gastroenterology & hepatology
Published: February 26, 2026
Predictors of Response to Induction Therapy with Ustekinumab in Patients with Ulcerative Colitis: Results from a National Study in Greece.
Journal: Diseases (Basel, Switzerland)
Published: January 25, 2026
Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class.
Journal: Journal of Crohn's & colitis
Published: November 03, 2025
Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class.
Journal: Journal of Crohn's & colitis
Published: November 03, 2025
Ustekinumab and Janus Kinase Inhibitors Outperform Vedolizumab as Second-line Therapy in Anti-tumor Necrosis Factor-experienced Patients With Ulcerative Colitis.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: October 07, 2025
Ustekinumab and Janus Kinase Inhibitors Outperform Vedolizumab as Second-Line Therapy in Anti-Tumor Necrosis Factor-Experienced Patients With Ulcerative Colitis.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: October 07, 2025
Ustekinumab and JAK inhibitors outperform vedolizumab as second-line therapy in anti-TNF-experienced patients with ulcerative colitis.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: October 07, 2025
Value of tofacitinib extended induction therapy in patients with moderate-to-severe ulcerative colitis: A real-world 52-week follow-up study.
Journal: World journal of gastroenterology
Published: July 01, 2025
Gaps between European Crohn's and Colitis Organisation quality standards of care and the real world on diagnosis and monitoring inflammatory bowel disease across Europe: results from the E-QUALITY survey.
Journal: Journal of Crohn's & colitis
Published: June 27, 2025
Gaps between European Crohn's Colitis Organisation quality standards of care and the real world on structure of IBD units across Europe: results from E-QUALITY survey.
Journal: Journal of Crohn's & colitis
Published: June 13, 2025
Last Updated: 09/26/2026